Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Multimedia
November 17, 2011
In this two-minute 2006 video clip, Ruth Levine, then CGD senior fellow and director for global health, tells the story of CGD’s Making Markets for Vaccines initiative. She describes how a CGD Working Group produced an economic and legal framework for funds to incentivize vaccine development. The G-...
Multimedia
November 08, 2011
Funding for HIV/AIDS has increased massively in the past few years. But is the money being used in the best possible way? In this short clip, CGD experts Nandini Oomman and Mead Over describe the HIV/AIDS monitor initiative which analyzes how PEPFAR, The Global Fund, and the World Bank deli...
Blog Post
November 08, 2011
My guest this week is Mead Over, one of the world’s leading experts on the global response to the HIV/AIDS pandemic. We discuss his new book, Achieving an Aids Transition: Preventing Infections to Sustain Treatment. The key idea is simple but powerful. Mead argues that, instead of reaching vain...
Multimedia
November 02, 2011
An estimated one billion people suffer from one or more neglected diseases like Tuberculosis, Malaria, Dengue Fever or others, and hundreds of millions of dollars have been spent to find effective treatments. Medicines, therapies and treatments have been discovered, but regulatory barriers in the la...
WORKING PAPERS
October 27, 2011
After a decade of rapid growth in average incomes, many countries have attained middle-income country (MIC) status, while poverty hasn’t fallen as much as one might expect. As a result, there are up to a billion poor people or a ‘new bottom billion’ living not in the world’s poorest countries but in...
Blog Post
October 24, 2011
In this Wonkcast, originally posted on July 2010, Tom Bollyky explains the problems that motivated him in establishing CGD’s Clinical Trials and Regulatory Pathways Working Group. The group’s final report, Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected D...